Insider filing · ARWR
Kenneth Allen Myszkowski
Chief Financial Officer
profile →
Arrowhead Pharmaceuticals, Inc.
ARWR · Healthcare · 34 filings in 24 months
ticker →
Kenneth Allen Myszkowski sold $893K of Arrowhead Pharmaceuticals (ARWR)
Executed Jan 6 2025, disclosed Jan 7 2025, 1 day later.
Value, as filed
$893K
45,167 sh across 4 lots
Executed
Jan 6 2025
the trade date, as filed
Disclosed
Jan 7 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KMKenneth Allen Myszkowski (Chief Financial Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $893K of ARWR (45,167 sh across 4 lots, as filed), executed Jan 6 2025.
The name
ARWRHealthcare · Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→